Press release
Narcolepsy Therapeutics Market Projected to Reach USD 7,852.93 Million by 2034, Growing at a CAGR of 7.5%
Narcolepsy Therapeutics Market
Market Preface
Narcolepsy is a condition that increases the sleepiness in people during the day and can cause them to fall asleep instantly. Some people also encounter other symptoms, such as muscle fragility, when they discern robust emotions. The healthcare provider may conjecture narcolepsy depending on the indications of excessive daytime sleeping and instant loss of muscle tone, known as cataplexy. The healthcare expert might suggest a sleep specialist.
Medicines that energize the central nervous system are the prominent cures to assist people with narcolepsy to stay awake in the course of the day. The healthcare expert may suggest modafinil or armodafinil. These medicines are not habit-configured as older stimulants. There are certain home remedies that one can follow, such as sticking to a schedule, such as going to sleep and waking up at allotted times, even during weekends.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/request-for-sample
Competitive Landscape
The market is aggressive in nature with several extensive multinationals and small and moderate sized firms. Some of the current players in the market are:
• Addrenex Pharmaceuticals, Inc.
• Arena Pharmaceuticals, Inc.
• Avadel Pharmaceuticals plc
• Axsome Therapeutics, Inc.
• BIOPROJET
• Graymark Healthcare, Inc.
• Harmony Biosciences Holdings, Inc.
• Janssen Global Services, LLC
• Jazz Pharmaceuticals plc
• NLS Pharmaceutics Ltd.
• Novartis AG
Narcolepsy Therapeutics Market Report Highlights
• Based on treatment, the narcolepsy with cataplexy segment dominated the narcolepsy therapeutics market share in 2024 due to the high prevalence of cataplexy among narcolepsy patients and the availability of effective treatments such as sodium oxybate. However, the narcolepsy without cataplexy segment is growing steadily as treatments for excessive daytime sleepiness gain traction.
• In terms of product, the sodium oxybate segment dominated the narcolepsy therapeutics market revenue in 2024, owing to its proven efficacy in treating both cataplexy and excessive daytime sleepiness in narcolepsy patients. The central nervous system stimulants segment is showing strong growth as a primary treatment for managing sleepiness.
• North America held the major market share in 2024 due to advanced healthcare infrastructure and high awareness levels. However, Asia Pacific is the fastest-growing region, fueled by improving healthcare access and rising awareness of narcolepsy.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/request-for-discount-pricing
Growth Drivers
Growing Consciousness: The identification and awareness of narcolepsy have enhanced lately, resulting in market growth. Research signifies that narcolepsy impacts roughly 37.7 of 100,000 persons in the US, paralleling approximately 126191 people nationwide. Growing consciousness in context to the condition has caused more individuals to adopt suitable treatments, thus propelling the narcolepsy therapeutics market forward.
Sizeable Progressions in Pharmacological Mediation: Notable advancements in pharmacological mediation have pushed the market demand. Current advancements involve the acceptance of medicines such as pitolisant and solriamfetol, which provide contemporary alternatives for handling immoderate daytime sleepiness and cataplexy. Further, continuing research into new treatment perspectives, such as orexin receptor agonists, targets to confront the fundamental causes of narcolepsy, essentially providing more productive and earmarked therapies in the time to come.
Market Segmentation
The narcolepsy therapeutics market segmentation is done on the basis of treatment, product, and region.
By treatment analysis, the narcolepsy with cataplexy segment holds the largest market share in 2024 due to the growing existence of cataplexy amongst narcoleptic patients.
By product analysis, the sodium oxybate segment dominated the market in 2024 due to elevated prescription rates, approving repayment schemes, and growing consciousness of narcolepsy treatments.
Global Narcolepsy Therapeutics Market, by Treatment
5.1. Key Findings
5.2. Introduction
5.2.1. Global Narcolepsy Therapeutics Market, by Treatment, 2020-2034 (USD Million)
5.3. Narcolepsy With Cataplexy
5.3.1. Global Narcolepsy Therapeutics Market, by Narcolepsy With Cataplexy, by Region, 2020-2034 (USD Million)
5.4. Narcolepsy Without Cataplexy
5.4.1. Global Narcolepsy Therapeutics Market, by Narcolepsy Without Cataplexy, by Region, 2020-2034 (USD Million)
5.5. Secondary Narcolepsy
5.5.1. Global Narcolepsy Therapeutics Market, by Secondary Narcolepsy, by Region, 2020-2034 (USD Million)
Global Narcolepsy Therapeutics Market, by Product
6.1. Key Findings
6.2. Introduction
6.2.1. Global Narcolepsy Therapeutics Market, by Product, 2020-2034 (USD Million)
6.3. Central Nervous System Stimulants
6.3.1. Global Narcolepsy Therapeutics Market, by Central Nervous System Stimulants, by Region, 2020-2034 (USD Million)
6.4. Sodium Oxybate
6.4.1. Global Narcolepsy Therapeutics Market, by Sodium Oxybate, by Region, 2020-2034 (USD Million)
6.5. Selective Serotonin Reuptake Inhibitor
6.5.1. Global Narcolepsy Therapeutics Market, by Selective Serotonin Reuptake Inhibitor, by Region, 2020-2034 (USD Million)
6.6. Tricyclic Antidepressants
6.6.1. Global Narcolepsy Therapeutics Market, by Tricyclic Antidepressants, by Region, 2020-2034 (USD Million)
6.7. Others
6.7.1. Global Narcolepsy Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market
Regional Analysis
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
Medical Devices Market
https://www.polarismarketresearch.com/industry-analysis/medical-devices-market
Placenta Market
https://www.polarismarketresearch.com/industry-analysis/placenta-market
Soft Tissue Sarcoma Treatment Market
https://www.polarismarketresearch.com/industry-analysis/soft-tissue-sarcoma-treatment-market
Neurothrombectomy Devices Market
https://www.polarismarketresearch.com/industry-analysis/neurothrombectomy-devices-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Narcolepsy Therapeutics Market Projected to Reach USD 7,852.93 Million by 2034, Growing at a CAGR of 7.5% here
News-ID: 4004831 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Narcolepsy
Key Trends Shaping the Future Narcolepsy Market From 2025-2034: Development Of E …
What industry-specific factors are fueling the growth of the narcolepsy market?
The rising number of obese individuals is expected to fuel the growth of the narcolepsy market. Obesity is increasing due to poor dietary habits, sedentary lifestyles, and environmental factors. Obesity can disrupt sleep patterns and lead to narcolepsy. The World Health Organization's March 2022 report indicated that approximately 1 billion people worldwide are obese, with the number continuing to rise.…
Obesity Fueling Narcolepsy Market Growth Driver: Leading Transformation in the N …
What Are the Projected Growth and Market Size Trends for the Narcolepsy Market?
The narcolepsy market has experienced swift expansion over the past few years. The market is projected to increase from $3.56 billion in 2024 to $3.99 billion in 2025, correspondingly reflecting a compound annual growth rate (CAGR) of 12.0%. The significant growth observed during the historic period is due to several factors, including heightened awareness regarding narcolepsy, advancements…
Major Force in the Narcolepsy Drugs Market 2025: Growing Demand For Personalized …
How Will the Narcolepsy Drugs Market Grow, and What Is the Projected Market Size?
In the last few years, the narcolepsy pharmaceuticals market has demonstrated robust growth. The market value, which stood at $3.62 billion in 2024, is projected to rise to $3.97 billion in 2025. This growth signifies a compound annual growth rate (CAGR) of 9.9%. The notable advancement during the historical period can be ascribed to factors such as…
Unlocking New Horizons in Narcolepsy Treatment
The Business Research Company recently released a comprehensive report on the Global Narcolepsy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the narcolepsy market size has…
Narcolepsy Therapeutics Market Insights, Forecast to 2031
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Narcolepsy Therapeutics market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the Narcolepsy Therapeutics market, including market size, trends, drivers and constraints, competitive aspects, and prospects…
Narcolepsy Drugs Market Trends and Dynamic 2028
Global Narcolepsy Drugs Market: Overview
The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques.
To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068
Moreover, constant development of…
